Publications


Publications

Other mycoses

  1. Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K, Chakrabarti A, Lanternier F, Pagano L, Skiada A, Akova M, Arendrup MC, Boekhout T, Chowdhary A, Cuenca-Estrella M, Freiberger T, Guinea J, Guarro J, de Hoog S, Hope W, Johnson E, Kathuria S, Lackner M, Lass-Florl C, Lortholary O, Meis JF, Meletiadis
  2. J, Munoz P, Richardson M, Roilides E, Tortorano AM, Ullmann AJ, van Diepeningen A, Verweij P, Petrikkos G. 2014. ESCMID and ECMM Joint Clinical Guidelines for the Diagnosis and Management of Mucormycosis 2013. Clin Microbiol Infect 20 Suppl 3:5-26. IF=4.5
  3. Espinel-Ingroff A, Arendrup MC, Pfaller MA, Bonfietti LX, Bustamante B, Canton E, Chryssanthou E, Cuenca-Estrella M, Dannaoui E, Fothergill A, Fuller J, Gaustad P, Gonzalez GM, Guarro J, Lass-Florl C, Lockhart SR, Meis JF, Moore CB, Ostrosky-Zeichner L, Pelaez T, Pukinskas SR, St-Germain G, Szeszs MW, Turnidge J. 2013. Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent? Antimicrob Agents Chemother 57:5836-5842. IF=4.4
  4. Fekkar A, Meyer I, Brossas JY, Dannaoui E, Palous M, Uzunov M, Nguyen S, Leblond V, Mazier D, Datry A. 2013. Rapid emergence of echinocandin resistance during Candida kefyr fungemia treatment with caspofungin. Antimicrob Agents Chemother 57:2380-2382. IF=4.4
  5. Seyedmousavi S, Guillot J, de Hoog GS. 2013. Phaeohyphomycoses, emerging opportunistic diseases in animals. Clinical Microbiology Reviews 26(1): 19-35 Arendrup MC, Boekhout T, Akova M, Meis JF, Cornely OA, Lortholary O, The ESCMID EFISG study group and ECMM, Arikan-Akdagli S, Cuenca-Estrella M, Dannaoui E, van Diepeningen AD, Groll AH, Guarro J, Guinea J, Hope W, Lackner M, Lagrou K, Lanternier F, Lass-Florl C, Meletiadis J, Munoz P, Pagano L, Richardson MD, Roilides E, Tortorano AM, Ullmann AJ. 2014. ESCMID/ECMM Joint Clinical Guideline for the Diagnosis and Management of Rare Invasive Yeast Infections. Clin Microbiol Infect 20 Suppl 3:76-98. IF=4.5
  6. Chowdhary A, Meis JF, Guarro J, de Hoog GS, Kathuria S, Arendrup MC, Arikan-Akdagli S, Akova M, Boekhout T, Caira M, Guinea J, Chakrabarti A, Dannaoui E, van Diepeningen A, Freiberger T, Groll AH, Hope WW, Johnson E, Lackner M, Lagrou K, Lanternier F, Lass-Florl C, Lortholary O, Meletiadis J, Munoz P, Pagano L, Petrikkos G, Richardson MD, Roilides E, Skiada A, Tortorano AM, Ullmann AJ, Verweij PE, Cornely OA, Cuenca-Estrella M. 2014. ESCMID/ECMM Joint Clinical Guidelines for the Diagnosis and Management of Systemic Phaeohyphomycosis: Diseases Caused by Black Fungi. Clin Microbiol Infect 20 Suppl 3:47-75. IF=4.5
  7. Dannaoui E, Millon L. 2014. Current status of diagnosis of Mucormycosis: update on molecular methods. Current Fungal Infection Reports 8:353-359.
  8. Fekkar A, Dannaoui E, Meyer I, Imbert S, Brossas JY, Uzunov M, Mellon G, Nguyen S, Guiller E, Caumes E, Leblond V, Mazier D, Fievet MH, Datry A. 2014. Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy? Eur J Clin Microbiol Infect Dis 33:1489-1496. IF=2.9
  9. Imbert S, Palous M, Meyer I, Dannaoui E, Mazier D, Datry A, Fekkar A. 2014. In vitro combination of voriconazole and miltefosine against clinically relevant molds. Antimicrob Agents Chemother 58:6996-6998. IF=4.4
  10. Tortorano AM, Richardson M, Roilides E, van Diepeningen A, Caira M, Munoz P, Johnson E, Meletiadis J, Pana ZD, Lackner M, Verweij P, Freiberger T, Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K, Chakrabarti A, Lanternier F, Pagano L, Skiada A, Akova M, Arendrup MC, Boekhout T, Chowdhary A, Cuenca-Estrella M, Guinea J, Guarro J, de Hoog S, Hope W, Kathuria S, Lortholary O, Meis JF, Ullmann AJ, Petrikkos G, Lass-Florl C. 2014. ESCMID & ECMM Joint Guidelines on Diagnosis and Management of Hyalohyphomycosis: Fusarium spp, Scedosporium spp, and others. Clin Microbiol Infect 20 Suppl 3:27-46. IF=4.5
  11. Compain F, Botterel F, Sitterle E, Paugam A, Bougnoux ME, Dannaoui E. 2015. In vitro activity of miltefosine in combination with voriconazole or amphotericin B against clinical isolates of Scedosporium spp. J Med Microbiol 64:309-311. IF=2.3
  12. Demanche C, Deville M, Michaux J, Barriel V, Pinçon C, Aliouat-Denis CM, Pottier M, Noël C, Viscogliosi E, Aliouat el M, Dei-Cas E, Morand S, Guillot J. 2015. What do Pneumocystis organisms tell us about the phylogeography of their hosts? The case of the woodmouse Apodemus sylvaticus in continental Europe and western Mediterranean islands. PLoS One 10(4): e0120839
  13. Espinel-Ingroff A, Chakrabarti A, Chowdhary A, Cordoba S, Dannaoui E, Dufresne P, Fothergill A, Ghannoum M, Gonzalez GM, Guarro J, Kidd S, Lass-Florl C, Meis JF, Pelaez T, Tortorano AM, Turnidge J. 2015. Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of Mucorales. Antimicrob Agents Chemother 59:1745-1750. IF=4.4
  14. Garnaud C, Botterel F, Sertour N, Bougnoux ME, Dannaoui E, Larrat S, Hennequin C, Guinea J, Cornet M, Maubon D. 2015. Next-generation sequencing offers new insights into the resistance of Candida spp. to echinocandins and azoles. J Antimicrob Chemother 70:2556-2565. IF=4.9
  15. Schwarz P, Dannaoui E, Gehl A, Felske-Zech H, Birngruber CG, Dettmeyer RB, Verhoff MA. 2015. Molecular identification of fungi found on decomposed human bodies in forensic autopsy cases. Int J Legal Med 129:785-791. IF=2.9
  16. Seyedmousavi S, Guillot J, Tolooe A, Verweij PE, de Hoog GS. 2015. Neglected fungal zoonoses: hidden threats to man and animals. Clinical Microbiology and Infections 21(5): 416-425
  17. Borman AM, Desnos-Ollivier M, Campbell CK, Bridge PD, Dannaoui E, Johnson EM. 2016. Novel taxa associated with human fungal black-grain mycetomas: Emarellia grisea gen. nov., sp. nov., and Emarellia paragrisea sp. nov. J Clin Microbiol 54:1738-1745. IF=3.6
  18. Bougnoux ME, Dannaoui E, Accoceberry I, Angoulvant A, Bailly E, Botterel F, Chevrier S, Chouaki T, Cornet M, Dalle F, Datry A, Dupuis A, Fekkar A, Gangneux JP, Guitard J, Hennequin C, Le Govic Y, Le Pape P, Maubon D, Ranque S, Sautour M, Sendid B, Chandenier J. 2016. Multicenter comparison of the Etest and EUCAST methods for antifungal susceptibility testing of Candida isolates to micafungin. Antimicrob Agents Chemother 60:5088-5091. IF=4.4
  19. Danesi P, da Rold G, Rizzoli A, Hauffe HC, Marangon S, Samerpitak K, Demanche C, Guillot J, Capelli G, de Hoog SG. 2016. Barcoding markers for Pneumocystis species in wildlife. Fungal Biology 120(2): 191-206
  20. Dannaoui E. 2017. Antifungal resistance in mucorales. Int J Antimicrob Agents. Aug 9. pii: S0924-8579(17)30302-3. doi: 10.1016/j.ijantimicag.2017.08.010. [Epub ahead of print] PubMed PMID: 28802855
  21. Espinel-Ingroff A, Arendrup M, Canton E, Cordoba S, Dannaoui E, Garcia-Rodriguez J, Gonzalez GM, Govender NP, Martin-Mazuelos E, Lackner M, Lass-Florl C, Linares Sicilia MJ, Rodriguez-Iglesias MA, Pelaez T, Shields RK, Garcia-Effron G, Guinea J, Sanguinetti M, Turnidge J. 2017. Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method. Antimicrob Agents Chemother 61:e01792-01716. IF=4.4
  22. Fakhim H, Chowdhary A, Prakash A, Vaezi A, Dannaoui E, Meis JF, Badali H. 2017. In Vitro Interactions of Echinocandins with Triazoles Against Multidrug-Resistant Candida auris. Antimicrob Agents Chemother. Aug 28. pii: AAC.01056-17. doi: 10.1128/AAC.01056-17. [Epub ahead of print] PubMed PMID: 28848002
  23. Fakhim H, Emami S, Vaezi A, Hashemi SM, Faeli L, Diba K, Dannaoui E, Badali H. 2017. In Vitro Activities of Novel Azole Compounds ATTAF-1 and ATTAF-2 against Fluconazole-Susceptible and -Resistant Isolates of Candida Species. Antimicrob Agents Chemother 61:e01106-01116. IF=4.4
  24. Levesque E, Rizk F, Noorah Z, Aït-Ammar N, Cordonnier-Jourdin C, El Anbassi S, Bonnal C, Azoulay D, Merle JC, Botterel F. Detection of (1,3)-β-d-Glucan for the Diagnosis of Invasive Fungal Infection in Liver Transplant Recipients. Int J Mol Sci. 2017 Apr 19;18(4). pii: E862. doi: 10.3390/ijms18040862
  25. Mousavi B, Costa JM, Arné P, Guillot J, Chermette R, Botterel F, Dannaoui E. 2017. Occurrence and species distribution of pathogenic Mucorales in unselected soil samples from France. Medical Mycology, In press
  26. Parize P, Boussaud V, Poinsignon V, Sitterlé E, Botterel F, Lefeuvre S, Guillemain R, Dannaoui E, Billaud EM. 2017. Clinical outcome of cystic fibrosis patients colonized by Scedosporium spp. following lung transplantation: a single-centre 15-year experience. Transpl Infect Dis In Press. IF=1.5
  27. Peano A, Pasquetti M, Tizzani P, Chiavassa E, Guillot J, Johnson E. 2017. Methodological issues in antifungal susceptibility testing of Malassezia pachydermatis. Journal of Fungi (sous presse)
  28. Prigent G, Ait-Ammar N, Levesque E, Fekkar A, Costa JM, El Anbassi S, Foulet F, Duvoux C, Merle JC, Dannaoui E, Botterel F. 2017. Echinocandin resistance in Candida species isolates from liver transplant recipients. Antimicrob Agents Chemother 61:e01229-01216. IF=4.4
  29. Seyedmousavi S, de M. G. Bosco S, de Hoog S, Ebel F, Elad D, Gomes RR, Jacobsen ID, Martel A, Mignon B, Pasmans F, Piecková E, Rodrigues AM, Singh K, Vicente VA, Wibbelt G, Wiederhold NP, Guillot J. Fungal infections in animals: a patchwork of different situations. Medical Mycology (sous presse)
  30. Toussaint B, Lanternier F, Woloch C, Fournier D, Launay M, Billaud E, Dannaoui E, Lortholary O, Jullien V. 2017. An ultra performance liquid chromatography-tandem mass spectrometry method for the therapeutic drug monitoring of isavuconazole and seven other antifungal compounds in plasma samples. J Chromatogr B Analyt Technol Biomed Life Sci 1046:26-33. IF=2.7